ElevenLabs' valuation doubled to $22 billion this week -- in a sale of existing shares, not a new funding round

ElevenLabs closed a $300 million employee tender offer Sept. 30 that values the voice-AI company at $22B (double February's price, paid for existing shares, not new capital). Wellington and T. Rowe Price co-led the transaction, joined by new backers BDT & MSD, EQT, GIC, Goldman Sachs, Ontario Teachers' Pension Plan and Sapphire Ventures, alongside existing investors including Andreessen Horowitz, ICONIQ Growth and D.E. Shaw. It is the second time in just over a year ElevenLabs has used this exact mechanism to reset its own headline number.

The number that will headline every story about this is also the one most likely to be misread. A tender offer is a sale of existing shares between investors and employees -- not a capital raise. The $300 million changing hands went to employees cashing out vested equity; none of it went into ElevenLabs' own accounts. The company raised $0 in new capital to hit $22 billion; it simply found institutional buyers willing to pay double February's price for stock that already existed.

The pattern has repeated three times in three years, each reset faster than the last. ElevenLabs priced its Series B at $1.1 billion in January 2024 and its Series C at $3.3 billion a year later -- both genuine primary rounds. Rather than a fourth priced round, September 2025 brought a $100 million employee tender at $6.6 billion, almost exactly double the Series C mark eight months earlier. February's Series D, a real $500 million capital raise, reset the number again to $11 billion. This week's tender doubles that figure once more, using the same mechanism as 2025: a sale of existing stock, not new money in the door. (Employee tenders have become a favored way for fast-growing AI startups to mark up paper wealth and retain staff between primary rounds, without the dilution of a new round or the disclosure that comes with an actual public listing.)

The business underneath the number is real, even without an audited price tag attached to it. ElevenLabs built its name on voice cloning, dubbing and narration -- the tools behind AI-dubbed video and audiobooks that made it a consumer-facing novelty back in 2023. The growth driver now is ElevenAgents, voice-based AI agents that handle live customer calls and conversations: the company says that product's own annualized revenue has grown more than 3x since February, now handling over 15 million conversations a week and resolving issues 31% faster than text-based chat agents on the same measure. Enterprise customers -- not individual consumers -- now account for 55% of total revenue, a real shift in what the company actually sells.

"AI should interact with people the way we interact with each other." -- Mati Staniszewski, CEO, ElevenLabs

Four times Suno is the comparison that puts the number in context. AI-music rival Suno closed a genuine primary round in June -- a $400 million Series D -- at a $5.4 billion valuation, on roughly $300 million of its own annualized revenue and 2 million paid subscribers. Both companies sell AI-generated audio; neither valuation was produced the same way. Suno's price came from new investors putting new money in at an institutionally negotiated term sheet. ElevenLabs' is a secondary-market price nobody but the shares' buyers and sellers has independently verified. The gap is still a real signal about where investors see more durable enterprise demand right now -- it just isn't an apples-to-apples one.

None of this is a referendum on whether ElevenLabs is actually worth $22 billion. There is no public market trading its stock, and a tender price is what one set of institutional buyers were willing to pay for existing shares on one specific day -- not an audited, third-party appraisal of the whole company. Chief executive Mati Staniszewski has told Bloomberg he wants the company IPO-ready within two to three years, with a dual listing that could include the Warsaw Stock Exchange -- the actual event that would finally put a market-tested, rather than a tender-market, number on ElevenLabs. What has to hold between now and then is the enterprise-revenue growth rate the company just reported; if it slows before a public listing prices the stock for real, $22 billion will turn out to have been a private number, not a lasting one.